Showing 3461-3470 of 9127 results for "".
Bimekizumab-bkzx Journal Scan: 4 Clinical Trials
https://practicaldermatology.com/topics/digital-supplement/bimekizumab-bkzx-journal-scan-4-clinical-trials/24128/Speed, depth, and durability from the first dual IL-17A/F inhibitor for the treatment of moderate to severe plaque psoriasis.The Placebo and Nocebo Effects in Dermatology
https://practicaldermatology.com/columns/clinical-focus-1/the-placebo-and-nocebo-effects-in-dermatology/23559/Increasing evidence suggests that these effects—though not fully understood—may be harnessed for patient care.Psychodermatology: A Review
https://practicaldermatology.com/topics/practice-management/psychodermatology-a-review/21180/Case Report: Minimal Incision Extraction for Large Lipomas
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-minimal-incision-extraction-for-large-lipomas/21189/Is Irritable Bowel Linked to Irritable Skin?
https://practicaldermatology.com/columns/clinical-focus-1/is-irritable-bowel-linked-to-irritable-skin/23324/Exploring irritable bowel syndrome’s link to dermatologic conditions.Impetigo: An Unconventional Case Report
https://practicaldermatology.com/topics/rare-disease/impetigo-an-unconventional-case-report/26246/Mauri Hart, a medical student at the Oklahoma State University College of Osteopathic Medicine, takes a look at a unique case study, and tests the reader's knowledge of impetigo.Vitiligo: An Update on Treatment Options
https://practicaldermatology.com/topics/skin-of-color/vitiligo-an-update-on-treatment-options/23995/From phototherapy to immunosuppresants to topical therapies, there are a number of treatment options for vitiligo.New In My Practice: TargetCool
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-targetcool/23971/Burnout and the Dermatologist
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/burnout-and-the-dermatologist/23874/SDRIFE Induced by Liposomal Daunorubicin and Cytarabine
https://practicaldermatology.com/youngmd-connect/resident-resource-center/sdrife-induced-by-liposomal-daunorubicin-and-cytarabine/20830/